Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -15.868% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) O=c1[nH]c(CN2CCN(c3ncccn3)CC2)nc2c(Br)cc(Br)cc12
b.) COc1ccccc1CCc1nnc(CCC(=O)N(C)Cc2cccc3ncccc23)o1
Answer: a. O=c1[nH]c(CN2CCN(c3ncccn3)CC2)nc2c(Br)cc(Br)cc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=c1[nH]c(CN2CCN(c3ncccn3)CC2)nc2c(Br)cc(Br)cc12
O=c1[nH]c(CN2CCN(c3ncccn3)CC2)nc2c(Br)cc(Br)cc12
6,8-dibromo-2-[(4-pyrimidin-2-ylpiperazin-1-yl)methyl]-3H-quinazolin-4-one